Regulation & law · 21/02/2019Updated: 10/17/2026 · 1 min read

US Government Responds to Comments on Antitrust Lawsuit Against CVS and Aetna

Summary

The US government has released its response to public comments on the antitrust lawsuit against CVS Health Corporation and Aetna Inc., which alleges that the two companies have engaged in anti-competitive practices.

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Regulation & law · 9/4/2026

US Government Proposes Final Judgment Against KKR & Co. Inc. and Other Companies

The US government has proposed a final judgment against KKR & Co. Inc. and other companies, alleging antitrust violations. The proposed judgment aims to address competitive concerns related to the companies' business practices.

Read summary →

Regulation & law · 9/11/2026

DOJ's EOIR Submits Information Collection Request for Review and Approval

The Executive Office for Immigration Review at the Department of Justice is requesting OMB review and approval for a previously approved information collection, with a request for public comments on the proposed revision and extension.

Read summary →

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/14/2026

Irvine Labs, Inc. Applies for Controlled Substances Importer Registration

Irvine Labs, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

AndersonBrecon, Inc DBA PCI Pharma Services Seeks Registration as Controlled Substance Importer

AndersonBrecon, Inc DBA PCI Pharma Services has submitted an application to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →